Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.
about
Interleukin-35: Expanding Its Job ProfileThe modulation of endoplasmic reticulum stress by chemical chaperone upregulates immune negative cytokine IL-35 in apolipoprotein E-deficient miceIncreased percentages of T cells producing interleukin-21 in patients with immune thrombocytopenic purpura.Decreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases.Function of interleukin-17 and -35 in the blood of patients with hepatitis B-related liver cirrhosis.Epstein-Barr virus-induced gene 3-deficiency leads to impaired antitumor T-cell responses and accelerated tumor growth.Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue.Epstein-Barr virus-induced gene 3 negatively regulates neuroinflammation and T cell activation following coronavirus-induced encephalomyelitis.IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells.Induced and natural regulatory T cells in the development of inflammatory bowel disease.The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte responseOral Escherichia coli colonization factor antigen I fimbriae ameliorate arthritis via IL-35, not IL-27.Interleukin 35 Polymorphisms Are Associated with Decreased Risk of Premature Coronary Artery Disease, Metabolic Parameters, and IL-35 Levels: The Genetics of Atherosclerotic Disease (GEA) Study.Autoimmunity in 2012.Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance.IL-35: a potential therapeutic target for controlling hepatitis B virus infection.IL-35 and Autoimmunity: a Comprehensive Perspective.T-helper cell-mediated factors in drug-induced liver injury.Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6 trans-signaling.Interluekin-35 in Asthma and Its Potential as an Effective Therapeutic Agent.The Immunobiology of Interleukin-35 and Its Regulation and Gene Expression.Gene Expression and Antiviral Activity of Interleukin-35 in Response to Influenza A Virus Infection.IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.A potential immunopathogenic role for reduced IL-35 expression in allergic asthma.Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.IL-27, but not IL-35, inhibits neuroinflammation through modulating GM-CSF expression.IL-35 may maintain homeostasis of the immune microenvironment in periodontitis.IL-35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells.Interleukin-35 Level Is Elevated in Patients with Chronic Hepatitis B Virus Infection.Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice.
P2860
Q26829619-60D8E150-1B77-4400-B95B-693A799A04F0Q28539349-6EC19CD3-0902-4FB0-A55F-F78BB7DD33D8Q33412014-3BE5A0C4-5447-418F-8851-2741890140B0Q34534000-D5DC34B1-6882-4DF3-B5C4-85C3B6677C1AQ34540813-DDBCA77E-C405-4D03-ABBE-CE0AA27A6E4DQ35799014-04778BC0-FD7E-4105-B557-2F1856C03EE1Q36005974-7A6564F3-0363-4E75-802C-22922485A181Q36346397-D63E7847-F67B-4E5A-A61E-67FFE629F306Q36501765-275AEBE2-65FA-425F-88D4-27D192021A9CQ36763672-7EE9CD6D-3A75-44E3-B938-3DB72816AB7EQ36948341-73AA6A87-5B44-42AD-8776-58196D7824B8Q37099883-C0EE32DA-48A5-4E7C-9E65-938AAC225E7AQ37519964-1E7C4D6F-F5A9-44B1-948D-F38272047C17Q37685707-00EDADC0-E6C8-4F83-855C-6EEAD0C9D5D0Q38131447-F6D3B0C7-C572-4EC5-9060-ECAF0D120722Q38154886-24028A7E-4E7C-4B8F-94BD-A1330B2F96B7Q38283391-3DEEE2AE-0A87-46F0-8541-0F70E22DC8D4Q38331780-BD0CB9B4-515A-4421-BB30-9FDEA3522D47Q38370632-136B54F0-203C-467B-8B02-8CEAFA63A379Q38712876-3D6B9F4C-267A-454C-B526-FA3B7D1B21E5Q39335458-B86DE3A4-8CDD-4DAA-9649-DCAA7B7D0D06Q40508635-381E58F1-70AC-4454-B50C-D2D9DDC46987Q40699208-575FCF72-9B02-4C6C-BEC9-1D8D0E4B59B0Q40760409-339133B5-79E7-494A-8BB1-8968334606E0Q40868049-AC3A85CC-0914-40E2-9750-0E40F45A5F49Q41685216-229D1F68-4FF1-4184-9024-77822B26293AQ45875154-CD4082B5-0AAA-48E5-AD84-5F03664EDE9BQ47145934-A4192C62-8E94-4E26-BB60-52FA9F80C770Q47343053-40B0F86E-9315-45F6-B7FE-690EBD87B49FQ47553800-834876B9-FBCA-4E56-BBFE-9EB15369862CQ51036730-2EC90656-90E1-4018-909B-05AAF48425C5Q54209318-A70A9EBC-C843-4A8D-A7DF-4CD8C0FB4175
P2860
Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Increased Th17 and regulatory ...... autoimmune encephalomyelitis.
@ast
Increased Th17 and regulatory ...... autoimmune encephalomyelitis.
@en
Increased Th17 and regulatory ...... autoimmune encephalomyelitis.
@nl
type
label
Increased Th17 and regulatory ...... autoimmune encephalomyelitis.
@ast
Increased Th17 and regulatory ...... autoimmune encephalomyelitis.
@en
Increased Th17 and regulatory ...... autoimmune encephalomyelitis.
@nl
prefLabel
Increased Th17 and regulatory ...... autoimmune encephalomyelitis.
@ast
Increased Th17 and regulatory ...... autoimmune encephalomyelitis.
@en
Increased Th17 and regulatory ...... autoimmune encephalomyelitis.
@nl
P2093
P2860
P356
P1476
Increased Th17 and regulatory ...... f autoimmune encephalomyelitis
@en
P2093
Caroline C Whitacre
Fu-Dong Shi
Jin-Qing Liu
Joanne Trgovcich
Joseph W Carl
Xue-Feng Bai
Xuejun Zhang
Zhenzhen Liu
P2860
P304
P356
10.4049/JIMMUNOL.1100106
P407
P577
2012-03-02T00:00:00Z